Q5U-64528-56281 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-23
Registered in v-safe
2021-06-23
Dose 1 — Janssen/Johnson & Johnson
2021-06-23
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Redness · None

Adult check-in
2021-06-24
Survey response — days 1–6 daily, dose 1
MedDRA: Chills, Hyperhidrosis — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chills. Sweating,

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache · Be unable to work or attend school

Adult check-in
2021-06-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-06-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-23	Janssen/Johnson & Johnson	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-06-24

Systemic reaction (other): Chills. Sweating,

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chills	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release